Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Glander

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2007
The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patientsTimm H Westhoff, Sven Schmidt, Petra Glander, et al.
Journal of Clinical Medicine|August 10, 2024
Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant RecipientsLutz Liefeldt, Johannes Waiser, Friederike Bachmann, et al.
Therapeutic Drug Monitoring|August 26, 2009
Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodiumBrenda C M de Winter, Teun van Gelder, Ron A A Mathot, et al.
British Journal of Clinical Pharmacology|April 28, 2015
No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover studyOlesja Rissling, Petra Glander, Pia Hambach, et al.
Therapeutic Drug Monitoring|April 1, 2009
Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cellsPetra Glander, Ferdi Sombogaard, Klemens Budde, et al.
Mabs|August 9, 2013
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 studyRuth Ladenstein, Silke Weixler, Bianca Baykan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 3, 2015
Pretransplant virtual PRA and long-term outcomes of kidney transplant recipientsLu Huber, Nils Lachmann, Matthias Niemann, et al.
Transplantation|February 8, 2011
Safety and efficacy of intensified versus standard dosing regimens of enteric-coated mycophenolate sodium in de novo renal transplant patientsClaudia Sommerer, Petra Glander, Wolfgang Arns, et al.
Pharmacogenetics and Genomics|July 21, 2009
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphismFerdi Sombogaard, Ron H N van Schaik, Ron A Mathot, et al.
BMC Nephrology|February 6, 2019
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipientsMichael Duerr, Eva V Schrezenmeier, Lukas J Lehner, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2007
The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patientsTimm H Westhoff, Sven Schmidt, Petra Glander, et al.
Journal of Clinical Medicine|August 10, 2024
Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant RecipientsLutz Liefeldt, Johannes Waiser, Friederike Bachmann, et al.
Therapeutic Drug Monitoring|August 26, 2009
Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodiumBrenda C M de Winter, Teun van Gelder, Ron A A Mathot, et al.
British Journal of Clinical Pharmacology|April 28, 2015
No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover studyOlesja Rissling, Petra Glander, Pia Hambach, et al.
Therapeutic Drug Monitoring|April 1, 2009
Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cellsPetra Glander, Ferdi Sombogaard, Klemens Budde, et al.
Mabs|August 9, 2013
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 studyRuth Ladenstein, Silke Weixler, Bianca Baykan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 3, 2015
Pretransplant virtual PRA and long-term outcomes of kidney transplant recipientsLu Huber, Nils Lachmann, Matthias Niemann, et al.
Transplantation|February 8, 2011
Safety and efficacy of intensified versus standard dosing regimens of enteric-coated mycophenolate sodium in de novo renal transplant patientsClaudia Sommerer, Petra Glander, Wolfgang Arns, et al.
Pharmacogenetics and Genomics|July 21, 2009
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphismFerdi Sombogaard, Ron H N van Schaik, Ron A Mathot, et al.
BMC Nephrology|February 6, 2019
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipientsMichael Duerr, Eva V Schrezenmeier, Lukas J Lehner, et al.
Pageof 5